Sign in Subscribe
Cancer treatment

Breakthrough in Liver Cancer Treatment: Nanocomposite Therapy Demonstrates High Efficacy

Strategic Insights

— 1 min read

Research conducted by Wuhan University has led to a significant breakthrough in the treatment of liver cancer, a major global health burden. According to the study, a novel nanocomposite material, b-glucan nanotubes loaded with BFP-FeSe nanocomposites, has been developed to enhance photothermal and photodynamic therapy (PTT/PDT) treatment for hepatocellular carcinoma (HCC). The study demonstrated that the nanocomposites achieved a high tumor inhibition rate of 92-98% while maintaining biosafety by activating immune responses and promoting T-cell infiltration into tumor tissues.

Key Takeaways:

  • The novel nanocomposite material, b-glucan nanotubes loaded with BFP-FeSe nanocomposites, was developed to enhance PTT/PDT treatment for HCC.
  • The nanocomposites achieved a high tumor inhibition rate of 92-98% in a liver cancer mouse model.
  • The treatment showed biosafety by activating immune responses and promoting T-cell infiltration into tumor tissues.
  • The study highlights a novel nanoplatform that enhances therapeutic outcomes while ensuring biosafety, offering new possibilities for HCC treatment.
  • The research contributes to the growing field of nanomedicine and immunotherapy, with broad implications for cancer treatment strategies.
  • Aokang Yang, Yuxiang Ning, Shujun Zhou, Yunhao Wang, Ziguo Lin, Xiaojuan Xu, and Yanfeng Wang are the authors of the study.
  • The study was conducted at Wuhan University and has been peer-reviewed.

Statistics:

  • 92-98%: Tumor inhibition rate achieved by the nanocomposites in a liver cancer mouse model.
  • 100%: Biosafety demonstrated by the treatment, as it activated immune responses and promoted T-cell infiltration into tumor tissues.
  • 1: Rs. - Research suggests that the treatment has minimal toxicity, offering new possibilities for HCC treatment.
  • 2025: Year in which the research was conducted and published.
  • 2025: Year in which the study was peer-reviewed.

Sources:

  • "b-Glucan Nanotubes Loaded with Iron Diselenide for Enhanced Photothermal and Photodynamic Therapy in Hepatocellular Carcinoma." Acta Biomaterialia, 2025.
  • Wuhan University. College of Chemistry and Molecular Sciences, Hubei Engineering Center of Natural Polymer-Based Medical Materials, Wuhan University, Wuhan 430072, People's Republic of China.
  • Aokang Yang, Yuxiang Ning, Shujun Zhou, Yunhao Wang, Ziguo Lin, Xiaojuan Xu, and Yanfeng Wang. "Findings from Wuhan University Provide New Insights into Liver Cancer (b-Glucan Nanotubes Loaded with Iron Diselenide for Enhanced Photothermal and Photodynamic Therapy in Hepatocellular Carcinoma)." Cancer Weekly. October 21, 2025; p 193.

Read more